MedChunk
Medically reviewed

What High Hemoglobin Level Requires Treatment?

Learn which high hemoglobin levels need medical evaluation, how doctors decide on treatment, common causes, tests to expect, and when symptoms need urgent care.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateDec 4, 2025 10 min read

There is no single hemoglobin level that automatically means treatment is needed. A mildly high result may only need a repeat blood test, especially if dehydration or altitude could explain it. Treatment is more likely when high hemoglobin persists, the hematocrit is elevated, symptoms or clotting risks are present, or a condition such as polycythemia vera is found. The next step is to identify the cause with a clinician.

Is There a Specific Hemoglobin Level That Requires Treatment?

A high hemoglobin result does not automatically mean you need medication or a procedure. Doctors consider how high the level is, whether it remains elevated on repeat testing, and whether other blood test results suggest an underlying problem. They also consider symptoms, medical history, medications, smoking habits, oxygen levels, and other relevant factors.

According to Mayo Clinic, a hemoglobin level above approximately 16.6 grams per deciliter (g/dL) in men or 15 g/dL in women is generally considered high. These values are general adult reference points, not treatment thresholds. Laboratory ranges can differ, and age, hydration, and altitude may affect the result. Children have different reference ranges depending on their age and sex.

The distinction between an abnormal result and a result requiring treatment is important. Someone with a slightly elevated level caused by temporary dehydration may need reassessment after the problem is corrected. A person with persistently elevated hemoglobin due to a bone marrow disorder may need treatment to reduce the risk of complications.

Why Does the Cause of High Hemoglobin Matter?

Hemoglobin is the protein in red blood cells that carries oxygen throughout the body. When hemoglobin is high, there may be more red blood cells than usual, or the blood may contain a higher concentration of red blood cells because its fluid component is reduced. The appropriate treatment depends on which situation is present and what caused it.

MedlinePlus explains that high hemoglobin can be associated with several factors and conditions, including dehydration, smoking, living at high altitude, heart or lung disease, sleep apnea, and polycythemia vera. Certain medicines and hormones, including testosterone, can also contribute to elevated levels.

Doctors generally distinguish between three broad situations:

  • Relative elevation: Dehydration or fluid loss can make hemoglobin appear high because there is less fluid in the bloodstream. This does not necessarily mean the body is producing excess red blood cells.
  • Secondary erythrocytosis: The body produces extra red blood cells in response to another factor, such as reduced oxygen levels related to a heart or lung condition.
  • Polycythemia vera: This is a bone marrow disorder in which the body produces too many red blood cells. It may also affect white blood cells and platelets and requires specific medical management.

These conditions can produce similar blood test results, but they do not always require the same treatment. A clinician needs to identify the underlying cause before deciding how to manage the elevation.

When Is Treatment More Likely to Be Needed?

When hemoglobin remains high on repeat testing

A result that stays above the laboratory's reference range deserves further assessment, especially if the hematocrit or other blood counts are also abnormal. Hematocrit measures the percentage of blood volume occupied by red blood cells. Doctors use it alongside hemoglobin and the red blood cell count to assess whether erythrocytosis may be present.

A persistently elevated result does not automatically require treatment to lower the blood count. It does, however, make it more important to determine whether the elevation is temporary, related to another health condition, or caused by a disorder of blood cell production.

When polycythemia vera is diagnosed

Polycythemia vera is a key reason doctors may recommend treatment to lower an elevated red blood cell count. The condition can increase the risk of blood clots, which may lead to serious complications. Treatment aims to reduce this risk and manage symptoms rather than simply bring a single hemoglobin reading into the laboratory's normal range.

According to the National Cancer Institute, treatment for polycythemia vera commonly uses blood removal, called phlebotomy, or medicines that reduce blood cell production to maintain hematocrit below 45%. This target applies to the management of polycythemia vera; it is not a universal treatment threshold for everyone with high hemoglobin.

When symptoms or clotting risks are present

Persistent headaches, dizziness, visual disturbances, unusual tiredness, or shortness of breath may occur in people with erythrocytosis. These symptoms have many possible causes, so they cannot establish the diagnosis on their own. However, symptoms that persist or worsen alongside abnormal blood results should be assessed by a healthcare professional.

A history of blood clots or other important risk factors can also affect treatment decisions. Depending on the cause and clinical findings, a specialist may recommend lowering the red blood cell count or using other measures to reduce the risk of complications.

What Treatment Is Used for High Hemoglobin?

Treatment depends on the underlying cause, the degree of elevation, and the person's overall health. Some people need only monitoring and correction of a temporary cause. Others require ongoing treatment and follow-up.

Correcting dehydration and other contributing factors

If dehydration is responsible for the elevated concentration, restoring fluid levels and addressing the reason for fluid loss may help the blood test return toward the expected range. A clinician may recommend repeat testing to confirm whether the elevation has resolved.

When smoking, sleep apnea, or a heart or lung disorder contributes to elevated hemoglobin, management focuses on that problem. Depending on the condition, care may involve smoking cessation support, treatment for disrupted breathing during sleep, or measures to improve oxygen levels. If a medicine or hormone is contributing, the prescriber may review its dose or consider an alternative. Medicines should not be stopped or changed without medical guidance.

Therapeutic phlebotomy

Therapeutic phlebotomy, also called venesection, involves removing a measured amount of blood through a vein. This reduces the number of circulating red blood cells and can lower hematocrit. It is a common treatment for polycythemia vera and may be used in selected cases of secondary erythrocytosis.

The Merck Manual Consumer Version notes that secondary erythrocytosis is generally managed by treating its cause, and phlebotomy is rarely needed in these cases. Removing blood without an appropriate indication can be unhelpful or harmful, so the decision should be made by a clinician who understands the underlying condition.

Medicines to manage blood counts or clotting risk

People with polycythemia vera may need medicines that reduce red blood cell production, depending on their risk factors and response to treatment. Some may also be prescribed low-dose aspirin to help reduce clotting risk when appropriate. Aspirin can increase bleeding risk, so it should not be started solely because a hemoglobin result is high.

For secondary erythrocytosis, medication choices depend on the cause. There is no single medicine that is suitable for every person with an elevated hemoglobin level.

How Do Doctors Decide Whether Treatment Is Necessary?

The evaluation usually begins with a review of the complete blood count (CBC), which includes hemoglobin, hematocrit, red blood cell count, and other blood cell measurements. If the finding is unexpected, the clinician may repeat the blood test and review factors such as hydration, smoking, altitude, and current medicines.

Further testing depends on the initial findings. It may include:

  • Oxygen assessment: To look for low oxygen levels that may be driving extra red blood cell production.
  • Erythropoietin testing: To measure a hormone involved in red blood cell production and help investigate the cause.
  • JAK2 genetic testing: To look for a genetic change associated with polycythemia vera when the condition is suspected.
  • Additional investigations: Depending on the findings, a clinician may recommend specialist blood tests, imaging, or other tests to investigate an underlying condition.

Not everyone needs every test. The combination of results helps determine whether monitoring is sufficient or whether treatment and referral to a blood specialist are appropriate.

When Does High Hemoglobin Need Urgent Medical Attention?

A high result found during routine testing often allows time for a planned medical review. However, certain symptoms require urgent assessment because they may indicate a blood clot or another serious problem.

The NHS guidance on erythrocytosis advises seeking immediate medical help when symptoms suggest a deep vein thrombosis or pulmonary embolism. These can include pain and swelling in one leg, sudden breathlessness, chest or upper back pain, coughing up blood, severe dizziness, or fainting.

Sudden weakness or numbness, difficulty speaking, new loss of balance, or other possible signs of a stroke also require emergency care. Do not wait for another blood test if these symptoms occur.

What Should You Do After a High Hemoglobin Result?

Start by reviewing the result with the healthcare professional who ordered the test. Ask how far the value is outside the laboratory's reference range, whether the hematocrit and other blood counts are also abnormal, and whether repeat testing or further investigations are needed.

Bring a list of medicines and supplements, and mention smoking, recent fluid loss, time spent at high altitude, sleep-related breathing problems, and any relevant heart or lung conditions. These details can help the clinician identify a possible explanation and decide on the next steps.

The main goal is not to lower every high hemoglobin result. It is to determine why the level is elevated and whether that cause or its associated risks need treatment. Some people need only follow-up, while others benefit from targeted treatment to reduce the risk of complications.

Frequently Asked Questions

Answers to common questions about high hemoglobin levels and treatment decisions.

Does a hemoglobin level of 18 g/dL always require treatment?

No. A level of 18 g/dL is elevated for most adults, but the number alone does not determine treatment. A clinician will consider the repeat result, hematocrit, symptoms, medical history, and possible causes. The next step may be further testing rather than immediate treatment to lower the blood count.

Can high hemoglobin return to normal without treatment?

Yes, in some cases. If dehydration or another temporary factor caused the elevated result, correcting that factor may help the level return toward the expected range. Persistent elevation caused by an underlying condition may require targeted treatment or regular monitoring.

Does everyone with high hemoglobin need blood removal?

No. Therapeutic phlebotomy is commonly used for polycythemia vera but is rarely needed for secondary erythrocytosis. Treatment depends on the underlying cause, symptoms, and risk of complications. Blood removal should be performed only when a healthcare professional determines that it is appropriate.

Which symptoms with high hemoglobin require emergency care?

Seek emergency medical care for sudden chest pain, severe or sudden breathlessness, coughing up blood, fainting, or possible stroke symptoms such as sudden weakness, numbness, or difficulty speaking. Pain and swelling in one leg may also indicate a blood clot and need urgent assessment.

Citations

  1. Mayo Clinic: High Hemoglobin Count
  2. MedlinePlus: Hemoglobin Test
  3. National Cancer Institute: Myeloproliferative Neoplasms Treatment
  4. Merck Manual Consumer Version: Secondary Erythrocytosis
  5. NHS: Erythrocytosis
Share this article